Axonal Damage and its Significance for the Concept of Neurodegeneration in Multiple Sclerosis

被引:3
|
作者
Recks, M. S. [1 ]
Bader, J. [1 ]
Kaiser, C. C. [2 ]
Schroeter, M. [2 ]
Fink, G. R. [2 ]
Addicks, K. [1 ]
Kuerten, S. [1 ]
机构
[1] Univ Cologne, Inst Anat 1, D-50931 Cologne, Germany
[2] Univ Cologne, Neurol Klin & Poliklin, D-50931 Cologne, Germany
关键词
axonal damage; demyelination; EAE; inflammation; MS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CYTOTOXIC T-LYMPHOCYTES; APPEARING WHITE-MATTER; AUTOIMMUNE ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODY; DEMYELINATION; LESIONS; INJURY; CNS; TRANSPORT;
D O I
10.1055/s-0029-1246014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In spite of tremendous scientific effort, the mechanisms underlying multiple sclerosis (MS) still remain to be elucidated. The prevalent pathogenetic concept adheres to the assumption of a strict hierarchical sequence of the triad inflammation, demyelination and axonal damage. However, recent studies have provided evidence that axonal pathology can occur independently of inflammation and demyelination. The present article critically re-evaluates the traditional paradigm of MS pathology. Potential cellular, humoral and metabolic mechanisms of axonal pathology are delineated and the development of isolated axonal damage is assessed. A better understanding of the pathological processes underlying MS is likely to result in an improvement of current therapeutic strategies. These should not only target the inflammatory, but also the neurodegenerative component of the disease.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 50 条
  • [21] Chronic Progressive Multiple Sclerosis - Pathogenesis of Neurodegeneration and Therapeutic Strategies
    Fitzner, Dirk
    Simons, Mikael
    CURRENT NEUROPHARMACOLOGY, 2010, 8 (03) : 305 - 315
  • [22] Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis
    Kennedy, Peter G. E.
    Fultz, Matthew
    Phares, Jeremiah
    Yu, Xiaoli
    BIOMOLECULES, 2024, 14 (10)
  • [23] Evidence of axonal damage in cerebellar peduncles without T2-lesions in multiple sclerosis
    Hannoun, Salem
    Kocevar, Gabriel
    Durand-Dubief, Francoise
    Stamile, Claudio
    Naji, Amal
    Cotton, Francois
    Cavallari, Michele
    Guttmann, Charles R. G.
    Sappey-Marinier, Dominique
    EUROPEAN JOURNAL OF RADIOLOGY, 2018, 108 : 114 - 119
  • [24] Lifespan neurodegeneration of the human brain in multiple sclerosis
    Coupe, Pierrick
    Planche, Vincent
    Mansencal, Boris
    Kamroui, Reda A.
    Koubiyr, Ismail
    Manjon, Jose V.
    Tourdias, Thomas
    HUMAN BRAIN MAPPING, 2023, 44 (17) : 5602 - 5611
  • [25] Neurodegeneration and neuroprotection in multiple sclerosis
    Davydovskaya, M. V.
    Boyko, A. N.
    Gusev, E. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2009, 109 (07) : 44 - 52
  • [26] Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis
    Brown, Dennis
    Moezzi, Dorsa
    Dong, Yifei
    Koch, Marcus
    Yong, V. Wee
    NEUROTHERAPEUTICS, 2021, 18 (01) : 387 - 400
  • [27] Neurodegeneration and Neuroprotection in Multiple Sclerosis
    Stangel, Martin
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (29) : 4471 - 4474
  • [28] Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications
    Simkins, Tyrell J.
    Duncan, Greg J.
    Bourdette, Dennis
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (06)
  • [29] Mechanisms of Neurodegeneration in Multiple Sclerosis
    Eliseeva D.D.
    Zakharova M.N.
    Neuroscience and Behavioral Physiology, 2023, 53 (3) : 324 - 332
  • [30] A New Perspective on Mechanisms of Neurodegeneration in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: the Early and Critical Role of Platelets in Neuro/Axonal Loss
    Orian, Jacqueline Monique
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2025, 20 (01)